Caristo Diagnostics operates in the healthcare technology sector, focusing on cardiovascular diagnostic tools. The company utilizes technology to assist in the detection of coronary inflammation, atherosclerosis, and plaque progression, which may aid in predicting cardiovascular risk and informing treatment decisions. Caristo Diagnostics serves the healthcare industry with an emphasis on preventive screening, disease diagnosis, and support for drug clinical trials, intervention planning, and clinical research.
